| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Revenue | $6.2B | $6.2B | $6.3B | $2.2B |
| Cost of Revenue | $3.9B | $3.9B | $4.1B | $4.0B |
| Gross Profit | $2.3B | $2.2B | $2.3B | $0.9B |
| R&D Expense | — | — | — | — |
| SG&A Expense | $2.0B | $2.0B | $1.8B | $1.9B |
| Operating Income | $0.3B | $0.2B | $0.5B | $0.3B |
| Net Income | $0.2B | $0.1B | $0.3B | $0.2B |
| EPS (Basic) | $2.11 | $1.41 | $4.24 | $2.82 |
| EPS (Diluted) | $2.05 | $1.39 | $4.14 | $2.70 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Total Assets | $4.5B | $4.6B | $4.7B | $4.3B |
| Current Assets | $1.4B | $1.5B | $1.7B | $1.7B |
| Cash & Equivalents | $0.2B | $0.3B | $0.4B | $0.5B |
| Total Liabilities | $3.9B | $4.2B | $4.3B | $4.1B |
| Current Liabilities | $1.4B | $1.6B | $1.6B | $1.7B |
| Stockholders' Equity | $0.6B | $0.4B | $0.4B | $0.3B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.4B | $0.4B | $0.9B |
| Investing Cash Flow | $-0.2B | $-0.3B | $-0.6B | $-0.2B |
| Capital Expenditures | $0.2B | $0.3B | $0.2B | $0.2B |
| Financing Cash Flow | $-0.3B | $-0.3B | $0.1B | $-0.5B |